0.02
Propanc Biopharma, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
0.02
FY24:
0.03
FY25:
8.35
FY26:
8.54
(positive)
Change from FY22 to FY26
millions USD
FY22:
0.07
FY23:
0.04
FY24:
0.05
FY25:
11.3
FY26:
4.24
Total assets
Change from FY22 to FY26
millions USD
FY22:
0.08
FY23:
0.06
FY24:
0.07
FY25:
19.6
FY26:
12.8
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
3.06
FY23:
3.16
FY24:
3.79
FY25:
5.58
FY26:
3.35
(negative)
Change from FY22 to FY26
millions USD
FY22:
0.04
FY23:
0.02
FY24:
0.06
FY25:
0.15
FY26:
0.02
(positive)
Change from FY22 to FY26
millions USD
FY22:
−3.02
FY23:
−3.12
FY24:
−3.78
FY25:
13.9
FY26:
9.40
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
0.08
FY23:
0.06
FY24:
0.07
FY25:
19.6
FY26:
12.8
All amounts in millions USD